Cargando…
Advances in co-opting anti-depressant drugs in glioma therapy
A study by Chryplewicz et al. demonstrated the efficacy of combining tricyclic antidepressant imipramine and anti-VEGF therapy in treating genetically engineered glioma models. Dual therapy synergistically improved vascular integrity, increased autophagy, and modulated the myeloid and lymphoid compa...
Autores principales: | Pant, Ayush, Lim, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797942/ https://www.ncbi.nlm.nih.gov/pubmed/36543105 http://dx.doi.org/10.1016/j.xcrm.2022.100837 |
Ejemplares similares
-
Organoids as a tool in drug discovery and patient-specific therapy for head and neck cancer
por: Done, Aaron J., et al.
Publicado: (2023) -
Co-targeting TGF-β and PD-L1 with radiation therapy: The Goldilocks principle
por: Bakhoum, Samuel F., et al.
Publicado: (2021) -
Making safe sense of an anti-sense!
por: Gill, Upkar S., et al.
Publicado: (2022) -
Cholinergic anti-inflammatory pathway and COVID-19
por: Mehranfard, Danial, et al.
Publicado: (2022) -
Advancing massive transcriptional profiling of single bacteria
por: Saliba, Antoine-Emmanuel
Publicado: (2023)